Cargando…
Concentrations of VEGF and PlGF Decrease in Eyes After Intravitreal Conbercept Injection
INTRODUCTION: Conbercept is a new anti-vascular endothelial growth factor drug approved for the treatment of age-related macular degeneration by the China Food and Drug Administration (CFDA) in 2013. In this study, we for the first time evaluated the concentrations of vascular endothelial growth fac...
Autores principales: | Zhou, Jun, Liu, Zheng, Chen, Meng, Luo, Zhi-Heng, Li, Yun-Qiu, Qi, Guang-Ying, Liu, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250636/ https://www.ncbi.nlm.nih.gov/pubmed/30377995 http://dx.doi.org/10.1007/s13300-018-0527-9 |
Ejemplares similares
-
PlGF, immune system and hypertension
por: Carnevale, Daniela, et al.
Publicado: (2015) -
Changes in concentrations of melatonin, PlGF, and cytokines in women with preeclampsia
por: Savka, Ruslan Florovych, et al.
Publicado: (2023) -
Physical activity differentially regulates VEGF, PlGF, and their receptors in the human placenta
por: Bhattacharjee, Jayonta, et al.
Publicado: (2021) -
PlGF Immunological Impact during Pregnancy
por: Albonici, Loredana, et al.
Publicado: (2020) -
A comparison of the diagnostic utility of the sFlt-1/PlGF ratio versus PlGF alone for the detection of preeclampsia/HELLP syndrome
por: Stepan, H., et al.
Publicado: (2016)